labeling changes for kaletra reflecting new qt/qtc interval and pr interval prolongation information

FDA News Labeling changes for Kaletra reflecting new QT/QTC interval and PR interval prolongation information Richard Klein & Kimberly Struble
April 6, 2009

Food and Drug Administration - April 6, 2009 Labeling changes for Kaletra reflecting new QT/QTC interval and PR interval prolongation information FDA approved, on April 6, 2009, changes to the product label for Kaletra (lopinavir/ritonavir) Tablets and Oral Solution, reflecting new WARNINGS and PRECAUTIONS regarding QT/QTC interval and PR interval prolongation information.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response CountyCare Offers Historic Opportunity to Improve Care for People with HIV International AIDS Advocates Demand China Give $1 Billion to Global Fund Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused CANADA: New Facility Unveiled for Homeless With Hepatitis C WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM Big jump in HIV among Navajo in New Mexico Policy change has yet to affect HIV-positive sailors UNAIDS reports more than 7 million people now on HIV treatment across Africa––with nearly 1 million added in the last year - while new HIV infections and deaths from AIDS continue to fall UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Navajo Confront an Increase in New H.I.V. Infections Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing
Copyright © 2009 -FDA News, Publisher. All rights reserved to Food and Drug (FDA) Administration FDA. Information in this article was accurate in April 6, 2009. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.